跳至主要内容
临床试验/IRCT20170917036227N4
IRCT20170917036227N4招募中3 期

Effect of cabergoline on myoma size and uterine bleeding in women with myomas attending to Arash Hospital

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
Female

入选标准

  • Uterin bleeding and pelvic pain
  • The size of the leiomyoma is between 3 and 8 cm
  • Aged between 20-50 years

排除标准

  • Post menopause
  • Pedunculated myoma
  • Use of Hormonal or lipid-lowering agents during the last 6 months
  • History of cardiovascular disease, venous thromboembolism, diabetes mellitus, liver and kidney disorders, hypertension
  • Other malignancies
  • Need or desire for lyomioma surgery in the next 3 months
  • Pregnancy and lactation
  • Uncontrolled hypertension

研究者

相似试验